The Dementias Platform UK (DPUK) Data Portal.


Journal

European journal of epidemiology
ISSN: 1573-7284
Titre abrégé: Eur J Epidemiol
Pays: Netherlands
ID NLM: 8508062

Informations de publication

Date de publication:
Jun 2020
Historique:
received: 14 02 2020
accepted: 10 04 2020
pubmed: 25 4 2020
medline: 26 9 2020
entrez: 25 4 2020
Statut: ppublish

Résumé

The Dementias Platform UK Data Portal is a data repository facilitating access to data for 3 370 929 individuals in 42 cohorts. The Data Portal is an end-to-end data management solution providing a secure, fully auditable, remote access environment for the analysis of cohort data. All projects utilising the data are by default collaborations with the cohort research teams generating the data. The Data Portal uses UK Secure eResearch Platform infrastructure to provide three core utilities: data discovery, access, and analysis. These are delivered using a 7 layered architecture comprising: data ingestion, data curation, platform interoperability, data discovery, access brokerage, data analysis and knowledge preservation. Automated, streamlined, and standardised procedures reduce the administrative burden for all stakeholders, particularly for requests involving multiple independent datasets, where a single request may be forwarded to multiple data controllers. Researchers are provided with their own secure 'lab' using VMware which is accessed using two factor authentication. Over the last 2 years, 160 project proposals involving 579 individual cohort data access requests were received. These were received from 268 applicants spanning 72 institutions (56 academic, 13 commercial, 3 government) in 16 countries with 84 requests involving multiple cohorts. Projects are varied including multi-modal, machine learning, and Mendelian randomisation analyses. Data access is usually free at point of use although a small number of cohorts require a data access fee.

Identifiants

pubmed: 32328990
doi: 10.1007/s10654-020-00633-4
pii: 10.1007/s10654-020-00633-4
pmc: PMC7320955
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

601-611

Subventions

Organisme : Medical Research Council
ID : MC_PC_19009
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/M009076/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N029453/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/L01341X/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R023484/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0600237
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0300429
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 107467/Z/15/Z
Pays : United Kingdom
Organisme : Parkinson's UK
ID : J-0901
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/L023784/2
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 202802/Z/16/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12019/3
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/P007058/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_17112
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00005/12
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0902227
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/L023784/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00019/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/M024962/1
Pays : United Kingdom
Organisme : Parkinson's UK
ID : H-1301
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/K013041/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_15018
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00019/3
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/S019669/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_EX_MR/N50192X/1
Pays : United Kingdom

Références

J Neurol Neurosurg Psychiatry. 2016 Sep;87(9):1034-6
pubmed: 26800710
J Alzheimers Dis. 2018;66(4):1635-1644
pubmed: 30452415
Lancet Neurol. 2017 Sep;16(9):701-711
pubmed: 28642124
Int J Epidemiol. 2013 Jun;42(3):689-700
pubmed: 22786799
Int J Epidemiol. 2012 Feb;41(1):33-42
pubmed: 21044979
BMJ Open. 2017 Jan 7;7(1):e013187
pubmed: 28064175
Sci Data. 2016 Mar 15;3:160018
pubmed: 26978244
Neurology. 2014 Jan 28;82(4):308-16
pubmed: 24363137
BMJ Open. 2012 Nov 19;2(6):
pubmed: 23166135
Int J Epidemiol. 2006 Oct;35(5):1140-5
pubmed: 16980700
J Parkinsons Dis. 2015;5(2):269-79
pubmed: 26405788
PLoS Med. 2015 Mar 31;12(3):e1001779
pubmed: 25826379
Int J Epidemiol. 2019 Feb 1;48(1):28-29e
pubmed: 29873753
Int J Epidemiol. 2013 Dec;42(6):1640-8
pubmed: 23143611
Environ Res. 2014 Oct;134:280-5
pubmed: 25194498
Int J Epidemiol. 2013 Feb;42(1):111-27
pubmed: 22507743
J Alzheimers Dis. 2017;60(1):283-293
pubmed: 28800330
Int J Epidemiol. 2014 Aug;43(4):1063-72
pubmed: 23771720
Int J Epidemiol. 2013 Feb;42(1):97-110
pubmed: 22507742
BMC Geriatr. 2018 Feb 9;18(1):45
pubmed: 29426299
BMC Geriatr. 2007 Dec 05;7:28
pubmed: 18053258
Alzheimers Res Ther. 2017 Aug 29;9(1):67
pubmed: 28851447
N Engl J Med. 2012 Aug 30;367(9):795-804
pubmed: 22784036
Mol Psychiatry. 2012 Dec;17(12):1316-27
pubmed: 22005930
J Epidemiol Community Health. 1984 Sep;38(3):259-62
pubmed: 6332166
PLoS One. 2015 Nov 23;10(11):e0141806
pubmed: 26599631
Neuroimage. 2017 Jan;144(Pt B):262-269
pubmed: 26375206
Brain. 2004 Mar;127(Pt 3):550-60
pubmed: 14691062
Int J Epidemiol. 2006 Feb;35(1):49-54
pubmed: 16204333
J Alzheimers Dis. 2018;66(2):681-691
pubmed: 30320571
Nat Commun. 2016 Apr 19;7:11398
pubmed: 27092707

Auteurs

Sarah Bauermeister (S)

Department of Psychiatry, University of Oxford, Oxford, UK.

Christopher Orton (C)

Swansea University Medical School, Swansea University, Swansea, UK.

Simon Thompson (S)

Swansea University Medical School, Swansea University, Swansea, UK.

Roger A Barker (RA)

Cambridge University Department of Clinical Neurosciences and Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.

Joshua R Bauermeister (JR)

Department of Psychiatry, University of Oxford, Oxford, UK.

Yoav Ben-Shlomo (Y)

Population Health Sciences, University of Bristol, Bristol, UK.

Carol Brayne (C)

Department of Public Health, University of Cambridge, Cambridge, UK.

David Burn (D)

Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.

Archie Campbell (A)

Department of Medical Genetics, University of Edinburgh, Edinburgh, UK.

Catherine Calvin (C)

Department of Psychiatry, University of Oxford, Oxford, UK.

Siddharthan Chandran (S)

Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.

Nishi Chaturvedi (N)

MRC Unit for Lifelong Health and Ageing, UCL, London, UK.

Geneviève Chêne (G)

Bordeaux Population Health, Université Bordeaux, Bordeaux, France.

Iain P Chessell (IP)

Neuroscience BioPharma R&D, AstraZeneca, Cambridge, UK.

Anne Corbett (A)

College of Medicine and Health, University of Exeter, Exeter, UK.

Daniel H J Davis (DHJ)

MRC Unit for Lifelong Health and Ageing, UCL, London, UK.

Mike Denis (M)

Oxford Academic Health Science Network, University of Oxford, Oxford, UK.

Carole Dufouil (C)

Bordeaux Population Health, Université Bordeaux, Bordeaux, France.

Paul Elliott (P)

MRC Centre for Environment and Health, School of Public Health, Imperial College London, London, UK.
Imperial College NIHR Biomedical Research Centre, Imperial College London, London, UK.
Health Data Research UK London at Imperial College London, London, UK.

Nick Fox (N)

Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, UK.

Derek Hill (D)

King's College London, London, UK.

Scott M Hofer (SM)

Department of Psychology, University of Victoria, Victoria, Canada.

Michele T Hu (MT)

Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.

Christoph Jindra (C)

Department of Psychiatry, University of Oxford, Oxford, UK.

Frank Kee (F)

Centre for Public Health, Queen's University Belfast, Belfast, UK.

Chi-Hun Kim (CH)

Department of Psychiatry, University of Oxford, Oxford, UK.

Changsoo Kim (C)

Department of Preventive Medicine, Yonsei University College of Medicine, Seoul, South Korea.

Mika Kivimaki (M)

Institute of Epidemiology and Health, University College London, London, UK.

Ivan Koychev (I)

Department of Psychiatry, University of Oxford, Oxford, UK.

Rachael A Lawson (RA)

Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.

Gerry J Linden (GJ)

Centre for Public Health, Queen's University Belfast, Belfast, UK.

Ronan A Lyons (RA)

Swansea University Medical School, Swansea University, Swansea, UK.

Clare Mackay (C)

Department of Psychiatry, University of Oxford, Oxford, UK.

Paul M Matthews (PM)

Division of Brain Sciences and UK Dementia Research Institute, Imperial College London, London, UK.

Bernadette McGuiness (B)

Centre for Public Health, Queen's University Belfast, Belfast, UK.

Lefkos Middleton (L)

MRC Centre for Environment and Health, School of Public Health, Imperial College London, London, UK.

Catherine Moody (C)

Medical Research Council, Swindon, UK.

Katrina Moore (K)

Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, UK.

Duk L Na (DL)

Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.

John T O'Brien (JT)

Department of Psychiatry, University of Cambridge, Cambridge, UK.

Sebastien Ourselin (S)

School of Biomedical Engineering & Imaging Sciences, King's College London, London, UK.

Shantini Paranjothy (S)

School of Medicine, Cardiff University, Cardiff, UK.

Ki-Soo Park (KS)

Institute of Health Science, Gyeongsang National University, Jinju-si, South Korea.

David J Porteous (DJ)

Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK.

Marcus Richards (M)

MRC Unit for Lifelong Health and Ageing, UCL, London, UK.

Craig W Ritchie (CW)

Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.

Jonathan D Rohrer (JD)

Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, UK.

Martin N Rossor (MN)

Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, UK.

James B Rowe (JB)

Cambridge University Department of Clinical Neurosciences and Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.

Rachael Scahill (R)

Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, UK.

Christian Schnier (C)

Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, UK.

Jonathan M Schott (JM)

Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, UK.

Sang W Seo (SW)

Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.

Matthew South (M)

Department of Psychiatry, University of Oxford, Oxford, UK.

Matthew Steptoe (M)

Department of Behavioural Science and Health, UCL, London, UK.

Sarah J Tabrizi (SJ)

Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, UK.

Andrea Tales (A)

Centre for Innovative Ageing, Swansea University, Swansea, UK.

Therese Tillin (T)

UCL Institute for Cardiovascular Science, London, UK.

Nicholas J Timpson (NJ)

Population Health Sciences, University of Bristol, Bristol, UK.

Arthur W Toga (AW)

Laboratory of Neuro Imaging, USC, Los Angeles, USA.

Pieter-Jelle Visser (PJ)

VU University Medical Centre, Maastricht University, Maastricht, The Netherlands.

Richard Wade-Martins (R)

Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, UK.

Tim Wilkinson (T)

Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, UK.

Julie Williams (J)

Institute of Psychological Medicine and Clinical Neurosciences, and UK Dementia Research Institute, Cardiff University, Cardiff, UK.

Andrew Wong (A)

MRC Unit for Lifelong Health and Ageing, UCL, London, UK.

John E J Gallacher (JEJ)

Department of Psychiatry, University of Oxford, Oxford, UK. john.gallacher@psych.ox.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH